Skip to content
Screener

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$588M-0.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Amgen logo
AmgenAMGN
2.8B0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1K0.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$681.93M+1,826%
Enterprise value$621.3M-5,241%
P/S681.9×+670×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
Line itemJune 30, 2026December 31,2025
Total liabilities9,5318,636
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.0001 par value: 300,000,000 shares authorized; 100,726,022 shares issued and outstanding at June 30, 2026 and 63,279,843 shares issued and outstanding at December 31, 2025107
Additional paid-in capital671,637512,906
Accumulated other comprehensive (loss) income(63)6
Accumulated deficit(460,448)(430,529)
Total stockholders’ equity211,13682,390

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s common stock?
Shattuck Labs, Inc. (STTK) reported common stock of 300M in Q2 2026.
How has Shattuck Labs, Inc.'s common stock changed year-over-year?
Shattuck Labs, Inc.'s common stock decreased by 0.0% year-over-year, from 300M to 300M.
What is the long-term trend for Shattuck Labs, Inc.'s common stock?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 300M to 300M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Shattuck Labs, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude